• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

STAAR Surgical announces management additions, promotions

Article

The company promotes two and adds another employee as it names three vice presidents.

Monrovia, CA-STAAR Surgical Co. has announced several additions to its senior management team.

James Francese has joined the company as vice president of global development; Robin Hughes has been named vice president of research and development, regulatory and quality; and Craig Felberg has been named vice president of business development.

“These leadership transitions are designed to help fuel our revenue growth in three ways: more effectively and aggressively market STAAR products globally, bring new products to market more quickly, and evaluate additional new technologies and business opportunities [that] will allow us to grow within our area of strategic focus,” said Barry Caldwell, STAAR chief executive officer.

Francese has 22 years of experience in ophthalmology, including 14 years marketing surgical products with Abbott Medical Optics (AMO) and Allergan. During his time at AMO, he served as head of marketing, Americas, for all surgical, refractive, and corneal products; head of global corneal marketing, responsible for all consumer products; and vice president of the Asia Pacific region.

Hughes has more than 20 years of experience in the ophthalmic industry, including the past 5 years as vice president of global marketing at STAAR.

Felberg has 30 years of experience in the ophthalmic surgical business, including the past 5 years as vice president of research and development at STAAR.

For more articles in this issue of Ophthalmology Times eReport, click here.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.